Context Therapeutics Inc.CNTXNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-8.73%
↑ 83% above average
Average (22q)
-50.73%
Historical baseline
Range
High:76.95%
Low:-505.51%
Volatility
-1148.2%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -8.73% |
| Q2 2025 | -76.49% |
| Q1 2025 | -28.27% |
| Q4 2024 | 76.95% |
| Q3 2024 | -505.51% |
| Q2 2024 | 19.22% |
| Q1 2024 | 44.85% |
| Q4 2023 | -12.18% |
| Q3 2023 | -16.78% |
| Q2 2023 | 20.61% |
| Q1 2023 | -71.71% |
| Q4 2022 | 4.09% |
| Q3 2022 | -1.00% |
| Q2 2022 | -16.41% |
| Q1 2022 | -11.35% |
| Q4 2021 | -97.18% |
| Q3 2021 | 68.80% |
| Q2 2021 | -498.05% |
| Q1 2021 | -9.20% |
| Q4 2020 | -18.20% |
| Q3 2020 | 0.08% |
| Q2 2020 | -30.33% |
| Q1 2020 | 0.00% |